Christopher G. Bunick, MD, PhD

Christopher G. Bunick, MD, PhD, is an associate professor of dermatology at Yale University School of Medicine.

Articles by Christopher G. Bunick, MD, PhD

Differentiating JAK Inhibitors From Other Therapies in AD

ByChristopher G. Bunick, MD, PhD,Peter Lio, MD ,Lisa Swanson, MD, PhD,Alexandra K. Golant, MD

November 28th 2023

Expert dermatologists discuss the factors that differentiate JAK inhibitors from other AD therapies, highlighting itch scores as they relate to quality of life.

Targeting the JAK-STAT Pathway in AD

ByChristopher G. Bunick, MD, PhD,Peter Lio, MD ,Lisa Swanson, MD, PhD,Alexandra K. Golant, MD

November 21st 2023

Alexandra Golant, MD; Christopher Bunick, MD, PhD; and Peter Lio, MD, comment on how targeting the JAK-STAT (signal transducer and activator of transcription) pathway with JAK inhibitors plays a role in managing AD.

Intro to Janus Kinase (JAK) Inhibitors for Treatment of Atopic Dermatitis (AD)

ByChristopher G. Bunick, MD, PhD,Peter Lio, MD ,Lisa Swanson, MD, PhD,Alexandra K. Golant, MD

November 21st 2023

Peter Lio, MD, and Lisa Swanson, MD, PhD, provide an overview of Janus Kinase (JAK) inhibitors, their pathophysiology, and their mechanism of action in the treatment of atopic dermatitis (AD).

Achieving Durable Clinical Response with Targeted Treatment for Vitiligo

ByRaj Chovatiya, MD, PhD,Christopher G. Bunick, MD, PhD

July 5th 2023

In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.

Achieving Durable Clinical Response with Targeted Treatments for Vitiligo

ByRaj Chovatiya, MD, PhD,Christopher G. Bunick, MD, PhD

July 5th 2023

Novel Systemic and Topical Treatment for Plaque Psoriasis

ByRaj Chovatiya, MD, PhD,Christopher G. Bunick, MD, PhD,Jason Hawkes, MD, MS

June 19th 2023

In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis

Novel Systemic and Topical Treatments for Plaque Psoriasis

ByRaj Chovatiya, MD, PhD,Christopher G. Bunick, MD, PhD,Jason Hawkes, MD, MS

June 19th 2023

In this episode of MEDcast, expert dermatologists discuss exciting advancements in systemic therapies such as JAK inhibitors, and the latest breakthroughs in topical treatments for plaque psoriasis.